Fused heterocyclic compounds as peptidase inhibitors
AssigneeTakeda Pharmaceutical Company Limited
InventorsSatoru Oi, Hironobu Maezaki, Koji Ikedou
Life of this patent
Estimating the term…
Abstract
A compound represented by the formula wherein ring A is an optionally substituted 5- to 10-membered aromatic ring; R1 and R2 are the same or different and each is an optionally substituted hydrocarbon group or an optionally substituted heterocyclic group; X and Y are the same or different and each is a bound, —O—, —S—, —SO—, —SO?2#191- or —NR3— (R3 is a hydrogen atom or an optionally substituted hydrocarbon group); and L is a divalent hydrocarbon group, or a salt thereof shows a superior peptidase-inhibitory activity and is useful as a prophylactic or therapeutic agent of diabetes and the like.
Claims11
A compound represented by the formula
- wherein
- ring A is an optionally substituted 5- to 10-membered aromatic ring;
- one of R1 and R2 is an optionally substituted phenyl group and the other is an optionally substituted C1-10 alkyl group;
- both X and Y are bonds:
- and
- L is a C1-10 alkylene group,
- or a salt thereof.
Dependencies are inferred from the claim text.